Matches in Wikidata for { <http://www.wikidata.org/entity/Q90346650> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q90346650 description "artículu científicu espublizáu en setiembre de 2019" @default.
- Q90346650 description "im September 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90346650 description "scientific article published on 26 September 2019" @default.
- Q90346650 description "wetenschappelijk artikel" @default.
- Q90346650 description "наукова стаття, опублікована 26 вересня 2019" @default.
- Q90346650 name "Tildrakizumab efficacy and safety are not altered by metabolic syndrome status in patients with psoriasis: Post hoc analysis of 2 phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2)" @default.
- Q90346650 name "Tildrakizumab efficacy and safety are not altered by metabolic syndrome status in patients with psoriasis: Post hoc analysis of 2 phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2)" @default.
- Q90346650 type Item @default.
- Q90346650 label "Tildrakizumab efficacy and safety are not altered by metabolic syndrome status in patients with psoriasis: Post hoc analysis of 2 phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2)" @default.
- Q90346650 label "Tildrakizumab efficacy and safety are not altered by metabolic syndrome status in patients with psoriasis: Post hoc analysis of 2 phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2)" @default.
- Q90346650 prefLabel "Tildrakizumab efficacy and safety are not altered by metabolic syndrome status in patients with psoriasis: Post hoc analysis of 2 phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2)" @default.
- Q90346650 prefLabel "Tildrakizumab efficacy and safety are not altered by metabolic syndrome status in patients with psoriasis: Post hoc analysis of 2 phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2)" @default.
- Q90346650 P1433 Q90346650-A8BB6D17-2A3E-427D-9B43-B81967306D55 @default.
- Q90346650 P1476 Q90346650-0C2579A3-4565-450C-85EF-4B056B3320FF @default.
- Q90346650 P2093 Q90346650-1D530B77-42DB-4F77-A461-586E91AD06B4 @default.
- Q90346650 P2093 Q90346650-51FF3CE3-05B4-40AD-AD0C-60062EF64D20 @default.
- Q90346650 P2093 Q90346650-8288120B-5A12-4A2A-BFD7-76F8463DD00F @default.
- Q90346650 P2093 Q90346650-8ADFCB5C-5A5B-4FB9-BE90-C6D3FFCD41C7 @default.
- Q90346650 P2093 Q90346650-98E88482-D8F7-47F4-8C08-1B4FF3500759 @default.
- Q90346650 P2093 Q90346650-D9148DEA-25CC-423F-AA61-942450043A4E @default.
- Q90346650 P2093 Q90346650-EF8DE2FE-8B93-4F57-88C5-2A489CC74E96 @default.
- Q90346650 P2093 Q90346650-F6186A2E-4F78-4220-9808-5D00ABE5D4F0 @default.
- Q90346650 P304 Q90346650-3FA8592F-7F10-4770-832E-0342E539F008 @default.
- Q90346650 P31 Q90346650-6791CF8D-91D0-4BFC-B0BC-E55F46F10B20 @default.
- Q90346650 P356 Q90346650-60E0B6AE-E25C-4921-B505-881FBDECD129 @default.
- Q90346650 P433 Q90346650-0C09316E-CA7D-48BA-92F8-3E5D719D400B @default.
- Q90346650 P478 Q90346650-6F6A735A-03D6-4359-BCE6-E8C6692F6FDA @default.
- Q90346650 P577 Q90346650-4F81E791-B929-4B49-8B7D-D20E96949425 @default.
- Q90346650 P698 Q90346650-3AC1C960-78B6-4629-AEA1-75039390AE31 @default.
- Q90346650 P921 Q90346650-A034F712-3901-43C8-9BA7-2A9D79B01FD8 @default.
- Q90346650 P356 J.JAAD.2019.09.042 @default.
- Q90346650 P698 31563641 @default.
- Q90346650 P1433 Q15757046 @default.
- Q90346650 P1476 "Tildrakizumab efficacy and safety are not altered by metabolic syndrome status in patients with psoriasis: Post hoc analysis of 2 phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2)" @default.
- Q90346650 P2093 "Alan M Mendelsohn" @default.
- Q90346650 P2093 "Alan Menter" @default.
- Q90346650 P2093 "Alice B Gottlieb" @default.
- Q90346650 P2093 "Craig L Leonardi" @default.
- Q90346650 P2093 "Jeff Parno" @default.
- Q90346650 P2093 "Mark G Lebwohl" @default.
- Q90346650 P2093 "Nehal N Mehta" @default.
- Q90346650 P2093 "Stephen J Rozzo" @default.
- Q90346650 P304 "519-522" @default.
- Q90346650 P31 Q13442814 @default.
- Q90346650 P356 "10.1016/J.JAAD.2019.09.042" @default.
- Q90346650 P433 "2" @default.
- Q90346650 P478 "82" @default.
- Q90346650 P577 "2019-09-26T00:00:00Z" @default.
- Q90346650 P698 "31563641" @default.
- Q90346650 P921 Q657193 @default.